retatrutide mechanism triple agonist glp-1 gip glucagon ly3437943 Retatrutide is not “just another GLP1.” It Retatrutide vs Tirzepatide Compared |

Overexpression of CHAC1 decreases cell viability and intracellular GSH levels, leading to increased sensitivity to the chemotherapeutic agent docetaxel (DTX)

With the increased addition of GSH, the color of Glud-MFo-c changed (Figure 6A), suggesting that Fe 3 (CN) 6 was reduced to Fe 2 (CN) 6 and GSH was converted to GSSG (Figure 6B)

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), along with glucose-dependent insulinotropic polypeptide (GIP) and glucagon (GCG) dual or triple receptor agonists that modulate multiple metabolic pathways, have attracted significant scientific interest due to their multifaceted roles in metabolic regulation

This discovery also paved the path to additional GLP-1 agonists, like tirzepatide , a dual agonist that targets both GLP-1 and GIP receptors for even greater metabolic impact